Discover 2,314 paid clinical trials in Oceanside, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 2,314
A Study of ICP-192 in Patients With Advanced Solid Tumors
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: La Jolla CA, Pasadena CA, Phoenix AZ, Gilbert AZ,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase3, Recruiting
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
TERPS Trial for de Novo Oligometastic Prostate Cancer
for
Prostate Cancer, Oligometastatic Disease
Location: La Jolla CA, Kansas City KS, Pittsburgh PA,
Sponsor: University of Maryland, Baltimore
Sex: Male
Age: 18+
Code: NCT05223803
Phase2, Recruiting
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
for
Solid Tumors, Hematologic Malignancies
Location: La Jolla CA, Duarte CA, Omaha NE, Houston TX,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07195916
Phase1, Recruiting
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
for
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: La Jolla CA, San Francisco CA, Salt Lake City UT,
Sponsor: AIDS Malignancy Consortium
Sex: All
Age: 18+
Code: NCT05663502
Recruiting
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
for
Metastatic Uveal Melanoma
Location: La Jolla CA, Los Angeles CA, Scottsdale AZ,
Sponsor: Replimune Inc.
Sex: All
Age: 0+
Code: NCT06581406
Phase2, Phase3, Recruiting
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
for
Pancreatic Ductal Adenocarcinoma (PDAC)
Location: La Jolla CA
Sponsor: University of California, San Diego
Sex: All
Age: 18+
Code: NCT06639724
Phase1, Recruiting
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
for
Gastrointestinal Stromal Tumor (GIST)
Location: La Jolla CA, Scottsdate AZ, Aurora CO, Rochester MN,
Sponsor: Deciphera Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT06630234
Phase1, Phase2, Recruiting
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
for
Pancreatic Cancer
Location: La Jolla CA
Sponsor: University of California, San Diego
Sex: All
Age: 18+
Code: NCT06205849
Phase1, Recruiting
Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
for
Cervical Cancer by FIGO Stage 2018
Location: La Jolla CA, Dallas TX, Little Rock AR, Burmingham AL,
Sponsor: Varian, a Siemens Healthineers Company
Sex: Female
Age: 18+
Code: NCT05197881
Recruiting
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: La Jolla CA, San Diego CA, Torrance CA, Los Angeles CA,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06479135
Phase3, Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
for
Clinical Stage III Cutaneous Melanoma AJCC v8,
Location: La Jolla CA, Los Angeles CA, Salt Lake City UT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05896839
Phase1, Phase2, Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
for
B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma,
Location: La Jolla CA, Santa Monica CA, Las Vegas NV,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT05006716
Phase1, Phase2, Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
for
Breast Cancer
Location: La Jolla CA, Irvine CA, Fullerton CA, Whittier CA,